Emerg Infect Dis by Wangchuk, Sonam et al.
can be mistaken for signs of tuberculosis. Considering the 
poor hygienic conditions among refugees, LBRF has be-
come an important differential diagnosis in Europe in times 
of increasing migration.
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To The Editor: Crimean-Congo hemorrhagic fever 
(CCHF) is a highly infectious tickborne disease caused 
by a high-risk group of viruses belonging to the family 
Bunyaviridae (1,2). In humans, the overall case-fatality 
rate of CCHF is ≈30%, but in severe and hospitalized 
patients, fatalities may be up to 80% (3,4). CCHF is 
widespread in various countries in Africa, Asia, and Eu-
rope; the virus had been identified in humans in China, 
Pakistan, and Afghanistan and has been recently report-
ed for the first time in humans in India (4–7). Humans 
can be infected by bites from infected ticks, mainly of 
the Hyalomma genus; by unprotected contact with blood 
or tissue of viremic patients; or during slaughtering of 
infected animals. In addition, nosocomial infections are 
found in humans (1,4,8,9).
Fatal cases of CCHF in humans were confirmed in 
Ahmadabad in India in 2011, but a recent serosurvey in 
livestock showed that this disease has widespread serop-
revalence in domestic animals across India (7–10). Bhutan 
shares a long, porous border with India, and animals and 
humans frequently cross the border. Comprehensive sur-
veillance was needed to determine the presence of CCHF 
virus (CCHFV) in livestock in Bhutan and to assess risk for 
zoonotic infection in humans.
During October 2015, in collaboration with the Na-
tional Centre for Animal Health Bhutan, we retrospective-
ly tested serum samples collected during April–May 2015 
from 81 goats and 92 cattle for CCHFV-specific IgG by 
using ELISA kits (Sheep/goat anti-CCHFV IgG ELISA kit 
and Cattle anti-CCHFV IgG ELISA kit; National Institute 
of Virology, Pune, India), as described (10). CCHFV IgG 
was detected in 31 (38.2%) goats; no cattle had positive 
results. The samples from goats, which were collected in 
early 2015 as part of surveillance of peste des petits ru-
minants, originated from the southern district of Sarpang, 
which shares a porous border with the state of Assam in 
India (Figure). The samples from cattle were collected 
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from the National Nublang Breeding Center (Trashigang 
district) and the National Jersey Breeding Center (Samtse 
district) (Figure). Findings indicated that all goats that 
tested positive for CCHFV were reported to have been 
either bred within households that kept goat herds or 
procured from other villages within the district. Exact 
sources of those seropositive goats could not be ascer-
tained. However, in a few instances in the past, breeding 
goats (male and female) were procured from India by the 
Bhutan government and distributed to farmers for breed 
improvement. We also believe that cross-border move-
ment of animals and unofficial imports of goats by farm-
ers along the porous borders of southern Bhutan likely 
occurred. Furthermore, a large number of dairy cattle are 
imported annually from India for enhancing milk pro-
duction and breeding purposes. Not all imported animals 
(both cattle and goats) were tested for CCHF because of a 
lack of diagnostic facilities and the negligible occurrence 
of the disease in livestock. 
Our findings indicate that the risk of importing 
emerging infectious diseases along with live animals 
poses a serious risk to public health. Consequently, 
detailed risk-based surveillance is necessary to under-
stand the complete scenario of CCHFV prevalence in 
livestock in Bhutan because Hyalomma tick species, the 
primary vectors of CCHF, are present on animals here. 
In addition, a survey among at-risk human populations 
is also needed. Findings from these surveillance activi-
ties would help institute more diagnostic facilities and 
risk-based surveillance and assist in developing a pre-
paredness plan at the human–animal interface. Although 
our study has limitations because of the low number of 
serum samples tested from limited animal species from 
only 3 areas, the study provides evidence that CCHFV is 
circulating in goats in Bhutan.
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Figure. Locations in Bhutan where serum samples were collected 
from goats (triangles) and cattle (square and circle) and tested 
for Crimean-Congo hemorrhagic fever virus. The shaded area 
shows the boundaries of Sarpang district and subdistricts, where 
samples from goats were collected.
